EQUILLIUM INC (EQ:NASDAQ)
$1.42 0.06 (4.4118%)
Analysed EQUILLIUM INC (EQ:NASDAQ) News Sources
Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis
20-05-2026
yahoo.com
Equillium Links AhR Activation to miR-124 as EQ504 Heads Toward Phase 1
29-05-2026
marketbeat.com
Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504
10-06-2026
yahoo.com
Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
13-08-2026
yahoo.com
Equillium to Participate in Upcoming Investor Conferences
02-09-2026
yahoo.com
Equillium to Participate in Stifel’s 2026 Virtual Immunology and Inflammation Forum
16-09-2026
yahoo.com
Equillium Eyes Q4 Phase I Start for Ulcerative Colitis Drug EQ504
27-09-2026
marketbeat.com
Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
05-10-2026
yahoo.com
Equillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference
06-10-2026
yahoo.com
Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504
26-10-2026
yahoo.com
What is the current price of EQUILLIUM INC (EQ:NASDAQ)?
The current price of EQUILLIUM INC (EQ:NASDAQ) is $1.42.
EQUILLIUM INC (EQ:NASDAQ) absolute price change since previous trading day?
The absolute price change of EQUILLIUM INC (EQ:NASDAQ) since the previous trading day is $0.06.
EQUILLIUM INC (EQ:NASDAQ) percentage price change since previous trading day?
The percentage price change of EQUILLIUM INC (EQ:NASDAQ) since the previous trading day is 4.4118%.
What is the most recent average sentiment score for EQUILLIUM INC (EQ:NASDAQ)?
The most recent average sentiment score for EQUILLIUM INC (EQ:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for EQUILLIUM INC (EQ:NASDAQ)?
The most recent sentiment for EQUILLIUM INC (EQ:NASDAQ) is .
SEC-8K** Filing Available For EQUILLIUM INC (EQ:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.